« Back to Record
Citation APA

Jessen, F., Arbizu, J., Boada, M., Balasa, M., Bennys, K., Boban, M., Bürger, K., Chincarini, A., Cagnin, A., De Deyn, P. P., Düzel, E., Engelborghs, S., Ewers, M., Exalto, L., van der Flier, W., Fortea, J., Frederiksen, K. S., Frisoni, G. G., Frölich, L., Garza-Martinez, A., Grimmer, T., Hanseeuw, B., Hort, J., Ivanoiu, A., Kehoe, P., Kennelly, S. P., Kern, S., Klöppel, S., Krajčovičová, L., Kramberger, M., McGuinness, B., Mecocci, P., Oberstein, T. J., Ousset, P.-J., Paquet, C., Perneczky, R., Piazza, F., Plantone, D., Rainero, I., Sacco, G., Salmon, E., Santana, I., Scarmeas, N., Schneider, A., Schott, J. M., Solje, E., Stefanova, E., Stögmann, E., Strauss, M., Sutovsky, S., Waldemar, G., & Winblad, B. (2025). Comment by European Alzheimer’s Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer’ s disease. The Journal of Prevention of Alzheimer's Disease, 12(8), 100259. doi:10.1016/j.tjpad.2025.100259


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/414993

Jessen, F., Arbizu, J., Boada, M., Balasa, M., Bennys, K., Boban, M., Bürger, K., Chincarini, A., Cagnin, A., De Deyn, P. P., Düzel, E., Engelborghs, S., Ewers, M., Exalto, L., van der Flier, W., Fortea, J., Frederiksen, K. S., Frisoni, G. G., Frölich, L., Garza-Martinez, A., Grimmer, T., Hanseeuw, B., Hort, J., Ivanoiu, A., Kehoe, P., Kennelly, S. P., Kern, S., Klöppel, S., Krajčovičová, L., Kramberger, M., McGuinness, B., Mecocci, P., Oberstein, T. J., Ousset, P.-J., Paquet, C., Perneczky, R., Piazza, F., Plantone, D., Rainero, I., Sacco, G., Salmon, E., Santana, I., Scarmeas, N., Schneider, A., Schott, J. M., Solje, E., Stefanova, E., Stögmann, E., Strauss, M., Sutovsky, S., Waldemar, G., & Winblad, B. (2025). Comment by European Alzheimer’s Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer’ s disease. The Journal of Prevention of Alzheimer's Disease, 12(8), 100259. doi:10.1016/j.tjpad.2025.100259